Publication Cover
Orbit
The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery
Volume 35, 2016 - Issue 1
317
Views
20
CrossRef citations to date
0
Altmetric
Clinical Research

Evaluation of a short-term topical interferon α-2b treatment for histologically proven melanoma and primary acquired melanosis with atypia

, , , , , , & show all
Pages 29-34 | Received 15 Jul 2015, Accepted 08 Sep 2015, Published online: 04 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Oliver Niels Klefter, Marie Louise Roed Rasmussen, Peter Bjerre Toft & Steffen Heegaard. (2018) Therapeutic options for conjunctival neoplasia. Expert Review of Ophthalmology 13:1, pages 17-31.
Read now

Articles from other publishers (19)

Jana Jiang, Daniel Böhringer, Claudia Auw-Hädrich, Philip Christian Maier, Teresa Barth, Nicole Eter, Matthias Fuest, Gerd Geerling, Ludwig M. Heindl, Martina Herwig-Carl, Christoph Hintschich, Katerina Hufendiek, Daniel Kampik, Wolfgang Lieb, Daniel Meller, Arthur Mueller, Norbert Pfeiffer, Matus Rehak, Marc Schargus, Berthold Seitz, Martin Spitzer, Andreas Stahl, Daniela Süsskind, Christian van Oterendorp, Felix Mathias Wagner, Henrike Westekemper, Focke Ziemssen & Thomas Reinhard. (2023) Current Practice in the Treatment of Epithelial and Melanocytic Tumours with Interferon-α2b: A Survey of Tertiary Eye Centres in Germany. Klinische Monatsblätter für Augenheilkunde 240:07, pages 891-896.
Crossref
Simone Nuessle, Claudia Auw-Haedrich, Jana Jiang, Daniel Boehringer & Thomas Reinhard. (2022) Real-life data of adjuvant IFN-α2b and MMC in conjunctival melanocytic lesions. Graefe's Archive for Clinical and Experimental Ophthalmology 261:4, pages 1159-1166.
Crossref
Pau Cid-Bertomeu & Valentín Huerva. (2022) Use of interferon alpha 2b to manage conjunctival primary acquired melanosis and conjunctival melanoma. Survey of Ophthalmology 67:5, pages 1391-1404.
Crossref
E. O’Neil, V. Lee & Joan M. O’Brien. 2022. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology 7983 8005 .
Sacha Nahon-Estève, Corine Bertolotto, Alexandra Picard-Gauci, Lauris Gastaud, Stéphanie Baillif, Paul Hofman, Anaïs Groulier, Célia Maschi, Jean-Pierre Caujolle, Sandra Lassalle & Arnaud Martel. (2021) Small but Challenging Conjunctival Melanoma: New Insights, Paradigms and Future Perspectives. Cancers 13:22, pages 5691.
Crossref
Mak B. Djulbegovic, Vladimir N. Uversky, J. William Harbour, Anat Galor & Carol L. Karp. (2021) Structural Protein Analysis of Driver Gene Mutations in Conjunctival Melanoma. Genes 12:10, pages 1625.
Crossref
Yue Zeng, Chunhong Hu, Long Shu, Yue Pan, Lishu Zhao, Xingxiang Pu & Fang Wu. (2021) Clinical treatment options for early-stage and advanced conjunctival melanoma. Survey of Ophthalmology 66:3, pages 461-470.
Crossref
Annemarie Klingenstein, Christina Samel, Elisabeth M Messmer, Aylin Garip-Kuebler, Siegfried G Priglinger & Christoph R Hintschich. (2021) Epidemiological characteristics and clinical course of eyelid squamous cell carcinoma patients from a large tertiary centre between 2009 and 2020. British Journal of Ophthalmology, pages bjophthalmol-2020-317969.
Crossref
Jayoon Moon, Se Hyun Choi, Min Joung Lee, Dong Hyun Jo, Un Chul Park, Sun-Ok Yoon, Se Joon Woo & Joo Youn Oh. (2021) Ocular surface complications of local anticancer drugs for treatment of ocular tumors. The Ocular Surface 19, pages 16-30.
Crossref
E. O’Neil, V. Lee & J. O’Brien. 2020. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology 1 23 .
Matthew J. Benage, Nicole C. Morrow, Ben J. Janson & Mark A. Greiner. (2019) Evaluation of interferon alpha 2b as adjunctive therapy for conjunctival melanoma. American Journal of Ophthalmology Case Reports 15, pages 100467.
Crossref
Natalia LewczukAlexander ZdebikJoanna Bogusławska. (2019) Interferon Alpha 2a and 2b in Ophthalmology: A Review. Journal of Interferon & Cytokine Research 39:5, pages 259-272.
Crossref
Ghada Al Bayyat, Dan Arreaza-Kaufman, Anat Galor, Jacob Pe’er & Carol L. Karp. 2019. Clinical Ophthalmic Oncology. Clinical Ophthalmic Oncology 245 259 .
Jacob Pe’er & Robert Folberg. 2019. Clinical Ophthalmic Oncology. Clinical Ophthalmic Oncology 197 207 .
Jacob Pe’er & Robert Folberg. 2019. Clinical Ophthalmic Oncology. Clinical Ophthalmic Oncology 185 195 .
T.A. Chaparro Tapias, A.L. Díaz Díaz, R. Secondi, H. Coy Villamil & J.C. Sánchez España. (2018) Resolution of conjunctival melanoma with topical interferon alpha 2b in a patient with mitomycin C intolerance. Archivos de la Sociedad Española de Oftalmología (English Edition) 93:11, pages 558-561.
Crossref
T.A. Chaparro Tapias, A.L. Díaz Díaz, R. Secondi, H. Coy Villamil & J.C. Sánchez España. (2018) Resolución de un melanoma conjuntival con interferón tópico alfa 2 b en un paciente con intolerancia a la mitomicina C. Archivos de la Sociedad Española de Oftalmología 93:11, pages 558-561.
Crossref
Iku Kikuchi, Satoru Kase, Kan Ishijima & Susumu Ishida. (2017) Long-term follow-up of conjunctival melanoma treated with topical interferon alpha-2b eye drops as adjunctive therapy following surgical resection. Graefe's Archive for Clinical and Experimental Ophthalmology 255:11, pages 2271-2276.
Crossref
. (2017) Pharmacotherapy and Immunotherapy of Conjunctival Tumors. Asia-Pacific Journal of Ophthalmology.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.